Elekta AB is trading at 5.69 as of the 17th of March 2025; that is 1.61% increase since the beginning of the trading day. The stock's open price was 5.6. Elekta AB has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
Elekta AB , a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden. Elekta B operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. The company has 382.08 M outstanding shares. More on Elekta AB ADR
Elekta AB ADR [EKTAY] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.9 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Elekta AB's market, we take the total number of its shares issued and multiply it by Elekta AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Elekta AB ADR classifies itself under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 382.08 M outstanding shares.
Elekta AB ADR has accumulated about 413.13 M in cash with 1.86 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.08.
Check Elekta AB Probability Of Bankruptcy
Our tools can tell you how much better you can do entering a position in Elekta AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Pair Correlation Now
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
When running Elekta AB's price analysis, check to measure Elekta AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elekta AB is operating at the current time. Most of Elekta AB's value examination focuses on studying past and present price action to predict the probability of Elekta AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elekta AB's price. Additionally, you may evaluate how the addition of Elekta AB to your portfolios can decrease your overall portfolio volatility.